Current hepatitis C therapy.

Q4 Medicine Casopis lekaru ceskych Pub Date : 2022-01-01
Petr Husa, Svatava Snopková, Petr Husa Ml
{"title":"Current hepatitis C therapy.","authors":"Petr Husa,&nbsp;Svatava Snopková,&nbsp;Petr Husa Ml","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Hepatitis C virus (HCV) infection is still a major cause of chronic liver diseases, with approximately 71 million chronically infected persons worldwide. People who inject drugs currently or in the past (PWID), mostly intravenously, are the main risk group among HCV chronically infected persons. The efficacy of therapy with direct acting antivirals (DAA) is almost 100 %. Currently, the main mission is to diagnose HCV infection in the most possible number of infected persons; it is in collision with poor adherence of PWID in particular.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 2","pages":"90-93"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Casopis lekaru ceskych","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Hepatitis C virus (HCV) infection is still a major cause of chronic liver diseases, with approximately 71 million chronically infected persons worldwide. People who inject drugs currently or in the past (PWID), mostly intravenously, are the main risk group among HCV chronically infected persons. The efficacy of therapy with direct acting antivirals (DAA) is almost 100 %. Currently, the main mission is to diagnose HCV infection in the most possible number of infected persons; it is in collision with poor adherence of PWID in particular.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
目前的丙型肝炎治疗。
丙型肝炎病毒(HCV)感染仍然是慢性肝病的主要原因,全世界约有7100万慢性感染者。目前或过去注射毒品的人(PWID),主要是静脉注射,是丙型肝炎病毒慢性感染者中的主要危险群体。直接作用抗病毒药物(DAA)治疗的疗效几乎为100%。目前,主要任务是在尽可能多的感染者中诊断丙型肝炎感染;特别是与PWID的不良依从性相冲突。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Casopis lekaru ceskych
Casopis lekaru ceskych Medicine-Medicine (all)
CiteScore
0.60
自引率
0.00%
发文量
31
期刊最新文献
Artificial intelligence in diabetic retinopathy screening: from idea to a medical device in clinical practice. Artificial intelligence in medicine and healthcare: Opportunity and/or threat. Artificial intelligence's contribution to early pulmonary lesion detection in chest X-rays: insights from two retrospective studies on a Czech population. Changes in contraceptive behavior in Czechia. Infertility problems in the context of reproductive ageing.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1